Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10085624 was granted and assigned to Olympus Group on October, 2018 by the United States Patent and Trademark Office. | 10085624 | October 2, 2018 | |||||||
Patent 10085728 was granted and assigned to Olympus Group on October, 2018 by the United States Patent and Trademark Office. | 10085728 | October 2, 2018 | |||||||
Patent 10058373 was granted and assigned to Olympus Group on August, 2018 by the United States Patent and Trademark Office. | 10058373 | August 28, 2018 | |||||||
Patent 7353068 was granted and assigned to Olympus Group on April, 2008 by the United States Patent and Trademark Office. | 7353068 | April 1, 2008 | |||||||
Patent 9983670 was granted and assigned to InteraXon on May, 2018 by the United States Patent and Trademark Office. | 9983670 | May 29, 2018 | |||||||
Patent 7879010 was granted and assigned to Roche on February, 2011 by the United States Patent and Trademark Office. | 7879010 | February 1, 2011 | |||||||
Patent 7331924 was granted and assigned to Olympus Group on February, 2008 by the United States Patent and Trademark Office. | 7331924 | February 19, 2008 | |||||||
Patent 10072082 was granted and assigned to Bristol-Myers Squibb on September, 2018 by the United States Patent and Trademark Office. | 10072082 | September 11, 2018 | |||||||
Patent 8472630 was granted and assigned to Roche on June, 2013 by the United States Patent and Trademark Office. | 8472630 | June 25, 2013 | |||||||
Patent 7563808 was granted and assigned to Eisai on July, 2009 by the United States Patent and Trademark Office. | 7563808 | July 21, 2009 | |||||||
Patent 7517546 was granted and assigned to Bayer on April, 2009 by the United States Patent and Trademark Office. | 7517546 | April 14, 2009 | |||||||
Patent 6946079 was granted and assigned to Bristol-Myers Squibb on September, 2005 by the United States Patent and Trademark Office. | 6946079 | September 20, 2005 | |||||||
11450147 | September 20, 2022 | ||||||||
Patent 7332303 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office. | 7332303 | February 19, 2008 | |||||||
Patent 12011590 was granted and assigned to Flow Neuroscience on June, 2024 by the United States Patent and Trademark Office. | 12011590 | June 18, 2024 | |||||||
Patent 11650159 was granted and assigned to Takeda Pharmaceutical Company on May, 2023 by the United States Patent and Trademark Office. | 11650159 | May 16, 2023 | |||||||
Patent 11786163 was granted and assigned to InteraXon on October, 2023 by the United States Patent and Trademark Office. | 11786163 | October 17, 2023 | |||||||
Patent 10085611 was granted and assigned to Olympus Group on October, 2018 by the United States Patent and Trademark Office. | 10085611 | October 2, 2018 | |||||||
Patent 7396675 was granted and assigned to Bayer on July, 2008 by the United States Patent and Trademark Office. | 7396675 | July 8, 2008 | |||||||
Patent 11426227 was granted and assigned to Olympus Group on August, 2022 by the United States Patent and Trademark Office. | 11426227 | August 30, 2022 | |||||||
Patent 11488311 was granted and assigned to Olympus Group on November, 2022 by the United States Patent and Trademark Office. | 11488311 | November 1, 2022 | |||||||
Patent 10365716 was granted and assigned to InteraXon on July, 2019 by the United States Patent and Trademark Office. | 10365716 | July 30, 2019 | |||||||
Patent 10584170 was granted and assigned to Bristol-Myers Squibb on March, 2020 by the United States Patent and Trademark Office. | 10584170 | March 10, 2020 | |||||||
Patent 7298393 was granted and assigned to Olympus Group on November, 2007 by the United States Patent and Trademark Office. | 7298393 | November 20, 2007 | |||||||
11553828 | January 17, 2023 |